ACADIA PHARMACEUTICALS INC — Director's Dealing 2013

Apr 12, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2013-04-11

Reporting Person: Baity Glenn (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-11	Common Stock	M	10000	$1.55	Acquired	50000	Direct
2013-04-11	Common Stock	S	10000	$11.06	Disposed	40000	Direct
2013-04-11	Common Stock	M	10000	$1.55	Acquired	50000	Direct
2013-04-11	Common Stock	S	10000	$12	Disposed	40000	Direct
2013-04-11	Common Stock	M	10000	$1.62	Acquired	50000	Direct
2013-04-11	Common Stock	S	10000	$13	Disposed	40000	Direct
2013-04-12	Common Stock	M	10000	$1.55	Acquired	50000	Direct
2013-04-12	Common Stock	M	10000	$1.55	Acquired	60000	Direct
2013-04-12	Common Stock	S	20000	$12.74	Disposed	40000	Direct
2013-04-12	Common Stock	M	10000	$1.62	Acquired	50000	Direct
2013-04-12	Common Stock	S	10000	$13	Disposed	40000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-11	Stock Option (right to buy)	$1.55	M	10000	Disposed	2020-03-11	Common Stock (10000)	Direct
2013-04-11	Stock Option (right to buy)	$1.55	M	10000	Disposed	2020-03-11	Common Stock (10000)	Direct
2013-04-11	Stock Option (right to buy)	$1.62	M	10000	Disposed	2021-03-24	Common Stock (10000)	Direct
2013-04-12	Stock Option (right to buy)	$1.55	M	10000	Disposed	2020-03-11	Common Stock (10000)	Direct
2013-04-12	Stock Option (right to buy)	$1.55	M	10000	Disposed	2020-03-11	Common Stock (10000)	Direct
2013-04-12	Stock Option (right to buy)	$1.62	M	10000	Disposed	2021-03-24	Common Stock (10000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2012.